INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 19.99 Million USD | 293.5% |
| 2022 | 5.08 Million USD | 61.02% |
| 2021 | 3.15 Million USD | -39.36% |
| 2020 | 5.2 Million USD | -5.53% |
| 2019 | 5.5 Million USD | 57.33% |
| 2018 | 3.5 Million USD | -33.41% |
| 2017 | 5.25 Million USD | 7.23% |
| 2016 | 4.9 Million USD | 13.08% |
| 2015 | 4.33 Million USD | -2.92% |
| 2014 | 4.46 Million USD | 13.45% |
| 2013 | 3.93 Million USD | 12.56% |
| 2012 | 3.49 Million USD | 14.57% |
| 2011 | 3.05 Million USD | 14.65% |
| 2010 | 2.66 Million USD | -24.46% |
| 2009 | 3.52 Million USD | 256.73% |
| 2008 | 988.12 Thousand USD | 44230.28% |
| 2007 | 2229.00 USD | 791.6% |
| 2006 | 250.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 16.66 Million USD | -8.95% |
| 2024 Q1 | 18.3 Million USD | -8.44% |
| 2023 FY | 19.99 Million USD | 293.5% |
| 2023 Q3 | 19.1 Million USD | 128.94% |
| 2023 Q4 | 19.99 Million USD | 4.67% |
| 2023 Q2 | 8.34 Million USD | 37.64% |
| 2023 Q1 | 6.06 Million USD | 19.31% |
| 2022 Q3 | 3.39 Million USD | 10.51% |
| 2022 Q4 | 5.08 Million USD | 49.85% |
| 2022 FY | 5.08 Million USD | 61.02% |
| 2022 Q1 | 2.93 Million USD | -7.15% |
| 2022 Q2 | 3.06 Million USD | 4.72% |
| 2021 Q1 | 4.59 Million USD | -11.77% |
| 2021 Q2 | 5.57 Million USD | 21.37% |
| 2021 FY | 3.15 Million USD | -39.36% |
| 2021 Q4 | 3.15 Million USD | -45.49% |
| 2021 Q3 | 5.78 Million USD | 3.89% |
| 2020 Q1 | 5.39 Million USD | -2.11% |
| 2020 FY | 5.2 Million USD | -5.53% |
| 2020 Q3 | 5.59 Million USD | -5.3% |
| 2020 Q2 | 5.9 Million USD | 9.48% |
| 2020 Q4 | 5.2 Million USD | -6.92% |
| 2019 Q2 | 6.55 Million USD | -0.77% |
| 2019 Q3 | 6.32 Million USD | -3.5% |
| 2019 FY | 5.5 Million USD | 57.33% |
| 2019 Q4 | 5.5 Million USD | -12.91% |
| 2019 Q1 | 6.6 Million USD | 88.65% |
| 2018 Q1 | 5.21 Million USD | -0.81% |
| 2018 FY | 3.5 Million USD | -33.41% |
| 2018 Q4 | 3.5 Million USD | -34.53% |
| 2018 Q3 | 5.34 Million USD | 1.36% |
| 2018 Q2 | 5.27 Million USD | 1.17% |
| 2017 Q1 | 4.9 Million USD | 0.12% |
| 2017 Q3 | 5.08 Million USD | 1.89% |
| 2017 Q2 | 4.98 Million USD | 1.55% |
| 2017 Q4 | 5.25 Million USD | 3.51% |
| 2017 FY | 5.25 Million USD | 7.23% |
| 2016 FY | 4.9 Million USD | 13.08% |
| 2016 Q3 | 4.73 Million USD | 3.17% |
| 2016 Q1 | 4.48 Million USD | 3.48% |
| 2016 Q2 | 4.58 Million USD | 2.18% |
| 2016 Q4 | 4.9 Million USD | 3.66% |
| 2015 FY | 4.33 Million USD | -2.92% |
| 2015 Q4 | 4.33 Million USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | 4.46 Million USD | 13.45% |
| 2013 FY | 3.93 Million USD | 12.56% |
| 2012 FY | 3.49 Million USD | 14.57% |
| 2011 Q3 | 3.06 Million USD | 0.25% |
| 2011 Q1 | 2.82 Million USD | 6.17% |
| 2011 Q4 | 3.05 Million USD | -0.37% |
| 2011 Q2 | 3.05 Million USD | 8.12% |
| 2011 FY | 3.05 Million USD | 14.65% |
| 2010 Q4 | 2.66 Million USD | 2.33% |
| 2010 Q3 | 2.6 Million USD | -0.8% |
| 2010 Q2 | 2.62 Million USD | 11.52% |
| 2010 Q1 | 2.35 Million USD | -33.27% |
| 2010 FY | 2.66 Million USD | -24.46% |
| 2009 FY | 3.52 Million USD | 256.73% |
| 2009 Q4 | 3.52 Million USD | -29.72% |
| 2009 Q1 | 1.39 Million USD | 41.02% |
| 2009 Q3 | 5.01 Million USD | 188.72% |
| 2009 Q2 | 1.73 Million USD | 24.67% |
| 2008 Q2 | 12.88 Thousand USD | 33.68% |
| 2008 Q1 | 9640.00 USD | 332.48% |
| 2008 Q4 | 988.12 Thousand USD | 4880.7% |
| 2008 Q3 | 19.83 Thousand USD | 53.95% |
| 2008 FY | 988.12 Thousand USD | 44230.28% |
| 2007 FY | 2229.00 USD | 791.6% |
| 2007 Q4 | 2229.00 USD | 0.0% |
| 2006 FY | 250.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 63.539% |
| Axonics, Inc. | 82.35 Million USD | 75.722% |
| CVRx, Inc. | 39.28 Million USD | 49.099% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 91.036% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -528.388% |
| MaxCyte, Inc. | 36.1 Million USD | 44.623% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 6.948% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 83.87% |
| Sintx Technologies, Inc. | 6.59 Million USD | -203.276% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 60.988% |
| Apyx Medical Corporation | 52.31 Million USD | 61.782% |
| Cutera, Inc. | 518.12 Million USD | 96.141% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -274.297% |
| NeuroPace, Inc. | 86.99 Million USD | 77.016% |
| IRIDEX Corporation | 24.91 Million USD | 19.744% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 77.226% |
| enVVeno Medical Corporation | 2.43 Million USD | -721.148% |
| TELA Bio, Inc. | 59.16 Million USD | 66.206% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.871% |
| UFP Technologies, Inc. | 118.04 Million USD | 83.062% |
| Modular Medical, Inc. | 2.27 Million USD | -780.06% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 31.823% |
| LENSAR, Inc. | 22.4 Million USD | 10.773% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.089% |
| Surmodics, Inc. | 65.82 Million USD | 69.623% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -93.768% |
| Inogen, Inc. | 121.38 Million USD | 83.527% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1094.442% |
| RxSight, Inc. | 22.18 Million USD | 9.884% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4601.588% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 32.406% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 13.569% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4601.588% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -723.075% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 80.885% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 97.158% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 21.474% |
| Dynatronics Corporation | 11.78 Million USD | -69.735% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 61.297% |
| InMode Ltd. | 75.91 Million USD | 73.661% |
| Bruker Corporation | 2.83 Billion USD | 99.295% |
| Movano Inc. | 5.97 Million USD | -234.812% |
| Orthofix Medical Inc. | 326.58 Million USD | 93.878% |
| FONAR Corporation | 57.45 Million USD | 65.2% |
| BioSig Technologies, Inc. | 4.68 Million USD | -326.787% |
| Envoy Medical, Inc. | 9.4 Million USD | -112.667% |
| Align Technology, Inc. | 2.45 Billion USD | 99.185% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 65.743% |
| Talis Biomedical Corporation | 29.22 Million USD | 31.58% |
| Cerus Corporation | 144.3 Million USD | 86.144% |
| 908 Devices Inc. | 37.49 Million USD | 46.666% |
| Nemaura Medical Inc. | 26.37 Million USD | 24.197% |
| Outset Medical, Inc. | 190.91 Million USD | 89.527% |
| NanoVibronix, Inc. | 2.68 Million USD | -644.414% |
| Venus Concept Inc. | 107.1 Million USD | 81.331% |
| Telesis Bio, Inc. | 40.87 Million USD | 51.08% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 82.456% |
| Quipt Home Medical Corp. | 136.29 Million USD | 85.329% |
| IRadimed Corporation | 20.73 Million USD | 3.573% |
| Tenon Medical, Inc. | 5.56 Million USD | -259.169% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -459.769% |
| Pulmonx Corporation | 60.63 Million USD | 67.025% |
| iCAD, Inc. | 8 Million USD | -149.906% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -57.559% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -982.031% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 50.981% |
| SI-BONE, Inc. | 61.05 Million USD | 67.248% |
| Semler Scientific, Inc. | 6.27 Million USD | -218.899% |
| Biotricity, Inc. | 35.91 Million USD | 44.334% |
| Cytosorbents Corporation | 29.98 Million USD | 33.318% |
| DexCom, Inc. | 4.19 Billion USD | 99.523% |
| ZimVie Inc. | 795.85 Million USD | 97.488% |
| Aethlon Medical, Inc. | 2.47 Million USD | -706.362% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -67.209% |
| IceCure Medical Ltd | 4.24 Million USD | -370.802% |
| PAVmed Inc | 57.13 Million USD | 65.005% |
| Sight Sciences, Inc. | 46.43 Million USD | 56.941% |
| Insulet Corporation | 1.85 Billion USD | 98.922% |
| Profound Medical Corp. | 12.66 Million USD | -57.865% |
| electroCore, Inc. | 8.94 Million USD | -123.532% |
| Bioventus Inc. | 589.79 Million USD | 96.61% |
| InspireMD, Inc. | 8.14 Million USD | -145.578% |
| PAVmed Inc. | 57.13 Million USD | 65.005% |
| Nuwellis, Inc. | 6.78 Million USD | -194.911% |
| OrthoPediatrics Corp. | 72.56 Million USD | 72.444% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -67.209% |
| BrainsWay Ltd. | 15.31 Million USD | -30.567% |
| BIOLASE, Inc. | 35.34 Million USD | 43.434% |
| Beyond Air, Inc. | 29.77 Million USD | 32.846% |
| AxoGen, Inc. | 101.16 Million USD | 80.235% |
| Inari Medical, Inc. | 209.32 Million USD | 90.448% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -814.761% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1023.944% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.366% |
| Quanterix Corporation | 78.08 Million USD | 74.393% |
| Viveve Medical, Inc. | 10.84 Million USD | -84.336% |
| LivaNova PLC | 1.15 Billion USD | 98.264% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -13.388% |
| Varex Imaging Corporation | 668.6 Million USD | 97.009% |
| Vivani Medical, Inc. | 25.03 Million USD | 20.135% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -392.002% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -459.769% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -309.313% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.086% |
| TransMedics Group, Inc. | 568.84 Million USD | 96.485% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -19.86% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1399.858% |
| Spectral AI, Inc. | 12.4 Million USD | -61.237% |
| Hyperfine, Inc. | 9.8 Million USD | -104.03% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 92.01% |
| Biomerica, Inc. | 2.66 Million USD | -650.843% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2304.969% |
| AVITA Medical, Inc. | 19.86 Million USD | -0.652% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -913.079% |
| Silk Road Medical, Inc | 114.15 Million USD | 82.485% |